Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Kovina Therapeutics operates as a pre-clinical biotechnology company.
Previse is a life sciences company focused on the development and commercialization of diagnostic tests for cancer prevention.
RIVANNA commercializes ultrasound technologies that reduce the patient risk caused by radiation from X-ray-based medical imaging.
Microvascular Therapeutics is a biotechnology company specializing in ultrasound contrast and theranostics for diagnosis.
Modifi Biosciences is a direct DNA modification developing novel cancer therapeutics.
VeraMorph is a pharmaceutical company that is developing an oral dosage technology based on polymers.
Linnaeus Therapeutics is a development stage biotech company that develops and commercializes drugs for cancer.
Trethera is a biotechnology company that discovers and develops small molecules that control DNA replication and integrity.
Paramita Therapeutics is a biotech company that focuses on developing new cancer and infectious disease therapeutics.
TransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.
QT Imaging is a scanning center that provides breast imaging by tomographic transmission ultrasound for patients.
Allterum Therapeutics is a biopharmaceutical company that develops treatments for different types of cancers.
Navrogen is a biopharmaceutical company that focuses on the targeted treatment of cancer.
MetasTx is creating treatments that prevent and treat prostate cancer metastasis without affecting the Androgen System.
Quiver Bioscience develops medicines for brain disorders using human disease models and AI to advance drug development.
Lamassu Pharma is a biotech startup that solves the critical unmet medical need for severe acute pancreatitis.
Tiga TX develops an IgA therapeutic monoclonal antibody platform for the treatment of solid tumors.
Palm Therapeutics is a next-generation therapeutics company to cure cancer at its source.
Xylyx Bio creates effective science-based solutions for the benefit of human life and health.
Ananya Health develops a medical device for treating cervical pre-cancer.
Voximetry is a healthtech software company that aims to give many cancer patients an alternative to chemotherapy.
Matter Bio operates as company focus on preserving genome integrity.
Saros Therapeutics is working to enhance patients' response to immunotherapy.
Current Surgical is a surgical device company that develops precise tools for the treatment of solid tumors.
National Cancer Institute has invested in 99 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Cancer Institute's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Medical Device. The firm invests across 19 different industry categories.
Among tracked funding rounds, Tiga TX received $35.5M in a Grant round. National Cancer Institute's total known invested capital is $319.4M.
National Cancer Institute's average investment size is $3.9M across its portfolio of 99 companies.
Recent National Cancer Institute portfolio additions include Kovina Therapeutics, Previse, RIVANNA, Microvascular Therapeutics, Modifi Bio. These companies were founded in 2020 or later.